Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa, Bertrand Routy, Antoine Desîlets, et al.
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2396-2412
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 844
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 315-324
Open Access | Times Cited: 408
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 704-712
Open Access | Times Cited: 321
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 321
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 213
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 111
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva, et al.
Science (2023) Vol. 380, Iss. 6649
Open Access | Times Cited: 95
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
Menglin Wang, Benoı̂t Rousseau, Kunyu Qiu, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 8, pp. 1263-1274
Closed Access | Times Cited: 80
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 80
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 73
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 54
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 50
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis
Satoru Yonekura, Safae Terrisse, Carolina Alves Costa Silva, et al.
Cancer Discovery (2021) Vol. 12, Iss. 4, pp. 1128-1151
Open Access | Times Cited: 71
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, et al.
Gut (2022) Vol. 71, Iss. 10, pp. 2107-2122
Open Access | Times Cited: 54
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors
Yusuke Tomita, Yoshihiko Goto, Shinya Sakata, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
The Role of The Tumor Microbiome in Tumor Development and Its Treatment
Yan Chen, Fahong Wu, Pengqiang Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Bodywide ecological interventions on cancer
Guido Kroemer, Jennifer L. McQuade, Miriam Mérad, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 59-74
Closed Access | Times Cited: 35
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 31
Microbiome influencers of checkpoint blockade–associated toxicity
Yinghong Wang, Robert R. Jenq, Jennifer A. Wargo, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 3
Open Access | Times Cited: 23
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1
Wei Ma, Lu Zhang, Weilong Chen, et al.
Protein & Cell (2024) Vol. 15, Iss. 6, pp. 419-440
Open Access | Times Cited: 13
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy
Siyuan Cheng, Zihan Han, Die Dai, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101355-101355
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top